Ethan Perlstein is an angel investor known for his work as the CEO of Perlara, a company that focuses on rare disease treatments. His investment approach emphasizes innovative solutions for health challenges, especially for rare genetic disorders. Through his role at Perlara, he is committed to navigating the complexities of biotech financing, bridging gaps between scientific discovery and the market.
Deal activity and portfolio updates would appear here
Connect your data source to see recent transactions